课题基金 / 基金详情

Molecular mechanism of membrane transport in the bacterial multidrug resistance proteins

Molecular mechanism of membrane transport in the bacterial multidrug resistance proteins
细菌多药耐药蛋白膜转运的分子机制
批准号:
327233-2006
负责人:
Dmitriev, Oleg
金额:
$3.21万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31

项目摘要

项目成果

Dmitriev, Oleg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this work is to understand the molecular mechanism of multidrug resistance in bacteria and to advance the methods of investigating the structure of membrane proteins by nuclear magnetic resonance spectroscopy (NMR).  Multidrug resistance refers to the ability of cancer and bacterial cells to expel various chemically different toxic compounds from the cell, thus undermining the effectiveness of chemo-therapy and antibacterial chemicals. Drug extrusion is facilitated by membrane proteins called multidrug transporters. The multidrug resistance protein MdfA from E.coli will be used as a model for studying the molecular mechanism of drug extrusion. We plan to analyze the global fold, or overall architecture, of MdfA, and to map the drug-binding site in the protein, using multi-dimensional NMR, a method uniquely suited for investigating small molecule bind-ing to proteins and for studying protein dynamics in solution.  The MdfA and related transporters use the energy of transmembrane ion gradients to pump drugs out of the cells. We will attempt to pinpoint the ion-binding site in the structure of the protein and to investigate changes in the fold of the protein, which may be involved in drug and ion binding and translocation across the cell membrane. To reach an atomic resolution in the future work on MdfA, we will try to crystallize the protein for solving the structure of MdfA by X-ray crystallography. This work will advance our understanding of the multiple drug resistance phe-nomenon in pathogenic bacteria and cancer cells, and, hopefully, will provide new ideas and contribute to the future development of new approaches to the chemotherapy of can-cer and to the development of new antibacterial treatments. The experimental approaches developed in the course of this project should be of interest to the broad research com-munity in the area of membrane protein biochemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanism of Regulation of the Human Copper Transporter ATP7B
  • 批准号:
    RGPIN-2017-06822
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.79万
  • 财政年份:
    2021
  • 负责人:
    Dmitriev, Oleg
  • 依托单位:
Molecular Mechanism of Regulation of the Human Copper Transporter ATP7B
  • 批准号:
    RGPIN-2017-06822
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2020
  • 负责人:
    Dmitriev, Oleg
  • 依托单位:
Molecular Mechanism of Regulation of the Human Copper Transporter ATP7B
  • 批准号:
    RGPIN-2017-06822
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2019
  • 负责人:
    Dmitriev, Oleg
  • 依托单位:
Molecular Mechanism of Regulation of the Human Copper Transporter ATP7B
  • 批准号:
    RGPIN-2017-06822
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2018
  • 负责人:
    Dmitriev, Oleg
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
  • 批准号:
    82371103
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮静
  • 依托单位: